Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

A cross-sectional pilot study of birth mode and vaginal microbiota in reproductive-age women Original paper

Researched by:

  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

November 20, 2025

Researched by:

  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

Last Updated: 2020-01-01

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Location
United States of America
Sample Site
Vaginal fluid
Species
Homo sapiens

What was studied?

This study examined the relationship between birth mode and vaginal microbiota in adulthood, evaluating whether being born by Cesarean section influences a woman’s likelihood of developing a low-Lactobacillus vaginal community state type (CST IV, also known as Molecular-BV). Using archived vaginal samples from two U.S. cohorts and newly collected survey data, the researchers assessed microbial composition via 16S rRNA gene sequencing and compared the prevalence of Lactobacillus-dominated versus dysbiotic CSTs. Birth mode and vaginal microbiota associations were analyzed with logistic regression, incorporating BMI as a key confounder.

Who was studied?

The study included 144 reproductive-age women originally enrolled in the HCL and VM400 studies. Participants were 17–44 years old, mostly nulliparous, and without active menstruation or recent antibiotic use at sampling. Twenty-seven women (19%) reported being born by C-section. Vaginal specimens were clinician- or self-collected depending on the parent study, and microbiota profiles were clustered into CSTs based on the relative abundance of Lactobacillus species versus BV-associated anaerobes. Marked demographic and behavioral differences existed between the two study cohorts, necessitating stratified analyses.

Most important findings

Across the combined cohort, C-section birth was associated with a non-significant trend toward higher odds of Molecular-BV (aOR 1.22). However, stratification revealed a stronger association in the HCL cohort, where C-section birth conferred approximately 3.5-fold higher odds of CST IV. The VM400 cohort showed no such association, likely due to differences in sample size and participant characteristics. Prevotella bivia emerged as the most discriminative taxon linked to C-section birth, with relative abundance ≥2.8% markedly increasing the probability that a woman was C-section–born. This species is a known marker of BV and a contributor to mucosal inflammation. Heatmap analyses visually confirmed greater prevalence of P. bivia and other BV-associated anaerobes in women with CST IV profiles, while Lactobacillus jensenii and L. iners trended higher among vaginally delivered women.

Key implications

The findings suggest that birth mode may exert a subtle yet persistent influence on vaginal microbial ecology into adulthood. C-section birth may predispose some women to a less protective vaginal environment characterized by reduced Lactobacillus dominance and greater abundance of BV-associated anaerobes such as P. bivia. Because Molecular-BV is linked to heightened risk of bacterial vaginosis, sexually transmitted infections, and adverse reproductive outcomes, early-life microbial exposures may represent a previously underappreciated determinant of long-term vaginal health. Larger longitudinal studies are needed to clarify causal pathways, incorporate maternal and early-childhood factors, and evaluate whether interventions such as microbial seeding or targeted probiotics could modify risk trajectories.

Citation

Stennett CA, Dyer TV, He X, Robinson CK, Ravel J, Ghanem KG, Brotman RM. A cross-sectional pilot study of birth mode and vaginal microbiota in reproductive-age women. PLoS One. 2020;15(4):e0228574. doi:10.1371/journal.pone.0228574

Bacterial Vaginosis

Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.